{"transactions":[{"id":2379001,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":130100,"kind":"person","name":"Kalled Susan","position":1,"cik":"0001860504","reported_name":"Kalled Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-23T17:30:41.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting 03/17/2022."}],"balance_after":60000,"derivative":{"exercise_price":2.4,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-22-007415","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860504/000089924322007415/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-18"}},{"id":2385744,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":130100,"kind":"person","name":"Kalled Susan","position":1,"cik":"0001860504","reported_name":"Kalled Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-18T18:55:43.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting 03/17/2022"}],"balance_after":60000,"derivative":{"exercise_price":2.52,"expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001171843-22-001208","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860504/000117184322001208/ownership.xml","form_type":"4"}},{"id":2727672,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":130100,"kind":"person","name":"Kalled Susan","position":1,"cik":"0001860504","reported_name":"Kalled Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-05T15:03:33.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on May 3, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":260000,"derivative":{"exercise_price":7,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0000899243-21-018319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860504/000089924321018319/doc4.xml","form_type":"4"}}]}